BIN1 and myotonic dystrophy type 1: DM1-associated splicing defects of DMD exon 78 and BIN1 exon 11 were clearly detected by the modified protocol, and treatment with the morpholino antisense oligonucleotide (ASO), CAG25, significantly restored nuclear MBNL1 aggregation and the splicing defects.